Geode Capital Management, LLC Inmune Bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
A detailed history of Geode Capital Management, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 389,931 shares of INMB stock, worth $943,633. This represents 0.0% of its overall portfolio holdings.
Number of Shares
389,931
Previous 364,862
6.87%
Holding current value
$943,633
Previous $2.85 Million
68.41%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding INMB
# of Institutions
102Shares Held
6.32MCall Options Held
1.64MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA848KShares$2.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.97 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.44 Million45.87% of portfolio
-
Ubs Group Ag449KShares$1.09 Million0.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$894,0390.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $43.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...